Xiangxue Pharmaceutical Co (SZSE:300147) ROCE % : 3.27% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Xiangxue Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 3.27%.

Xiangxue Pharmaceutical Co ROCE % Historical Data

The historical data trend for Xiangxue Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangxue Pharmaceutical Co ROCE % Chart

Xiangxue Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

5.05

5.13

-8.74

-7.71

-4.65

Xiangxue Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															7.53	0.07	-1.47	-23.96	3.27

Xiangxue Pharmaceutical Co ROCE % Calculation

Xiangxue Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-151.892	/	( ( (8642.021 - 5233.136)	+	(8280.63 - 5161.682) )	/ 2 )
	=	-151.892	/	( (3408.885	+	3118.948)	/ 2 )
	=	-151.892	/	3263.9165
	=	-4.65 %

Xiangxue Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	101.528	/	( ( (8280.63 - 5161.682)	+	(8240.218 - 5152.53) )	/ 2 )
	=	101.528	/	( ( 3118.948	+	3087.688 )	/ 2 )
	=	101.528	/	3103.318
	=	3.27 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Xiangxue Pharmaceutical Co (SZSE:300147) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Xiangxue Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiangxue Pharmaceutical Co (SZSE:300147) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663

Website

http://www.xphcn.com

Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.

Executives

Huang Wei Hua	Supervisors
Tan Wen Hui	Director
Kang Zhi Ying	Executives
Ceng Lun	Executives
Liu Yan	Executives
Lu Feng	Executives
Xu Li	Secretary, Director
Mo Zi Yu	Supervisors
Mai Zhen Jiang	Supervisors
Wang Yong Hui	Directors, executives
He Tao	Executives
Fang Wei Min	Supervisors
Huang Bin	Directors, Directors, and Executives
Wu Jun	Executives
Chen Wen Jin	Executives

Xiangxue Pharmaceutical Co (SZSE:300147) Headlines

No Headlines